Teva announced the launch of Amikacin Sulfate Injection, the generic version of Bristol-Myers Squibb’s Amikin Injection.

Amikacin Sulfate is an aminoglycoside antibacterial indicated for short-term treatment of serious susceptible infections, including septicemia, respiratory tract, bones and joints, CNS (eg, meningitis), skin and skin structure, intra-abdominal (eg, peritonitis), burns and postoperative infections, complicated and recurrent UTIs or uncomplicated UTIs not susceptible to other antibiotics.

RELATED: Teva Launches Generic Lovenox Injection

Amikacin Sulfate Injection 250mg/mL is available in the NOVAPLUS label as 2mL and 4mL vials in 10-count packs.

For more information call (888) 838-2872 or visit